RxDoctor Payments Data

John Lake, MD

Psychiatry · Cape Girardeau, MONPI 1629270194

Payments from drug & device makers

$1,791in general payments, 2019–2025

Across 113 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$827
  • Johnson & Johnson$404
  • Otsuka America Pharmaceutical, Inc.$164
  • Axsome Therapeutics, Inc.$111
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$82
  • Lundbeck LLC$70
  • plus $132 from 4 others

What the payments were for

  • Food & beverage$1,791100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,791 in reported general payments places this provider in the 70th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Medicare billing

Part B allowed, 2024
$43,787
Medicare patients
107
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl12$18,355
Paliperidone ErPaliperidone13$9,382
AuvelityDextromethorphan Hbr/Bupropion13$6,468
Aripiprazole37$4,637
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine86$2,964
Eszopiclone39$2,399
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl12$2,030
Oxcarbazepine28$1,945
Venlafaxine Hcl ErVenlafaxine Hcl125$1,906
Armodafinil22$1,535
Mirtazapine120$1,411
Methylphenidate Hcl42$1,329
Duloxetine Hcl47$1,159
Clonazepam155$1,088
Alprazolam185$1,020

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$827$18,35512 claims
Axsome Therapeutics, Inc.Auvelity$111$6,46813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 680 psychiatry providers in Missouri.

Other psychiatry in Cape Girardeau

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →